Aspira Pathlab & Diagnostics

quarterly
yearly
ParticularsDec '21Mar '22Jun '22Sep '22Dec '22
Revenue4.735.442.973.714.37
Expenses3.803.873.213.653.95
EBITDA0.931.57-0.240.060.42
EBIT0.561.06-0.66-0.340.03
Profit Before Tax0.871.44-0.290.020.44
Net Profit0.871.44-0.290.020.44
Financial Ratios
Operating Profit Margin19.66%28.86%-8.08%1.62%9.84%
Net Profit Margin18.39%26.47%-9.76%0.54%10.07%
Earning Per Share (Diluted)0.841.40-0.280.010.43
Dividends Per ShareNANANANANA
ⓒ 2016-2023 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 3.8.0
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI